Atif Zia

Atif Zia joined Septodont in 2009 to lead Septodont’s Cambridge site as Vice-President and General Manager. Atif’s executive responsibilities expanded to include the Louisville site in 2013 and DLA Pharma in Brazil in 2016.

In late 2015 Atif was appointed President of Novocol Healthcare to drive the group’s diversification strategy into the pharma market through the Cambridge and Louisville manufacturing sites. Atif joined the Corporate Executive Committee in April 2018.

Prior to joining Septodont, Atif spent 14 years at Apotex, having served in a wide range of operations leadership roles. During his tenure there he made a significant impact on the company’s rapid growth in becoming a world leader in generic ophthalmics, injectables, nasal sprays, and oral liquids.

Atif graduated from the University of Toronto with a degree in Human Biology and is currently an MBA candidate at the Rotman School of Management.